Found 8 matching trials
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease PHASE2 This study is researching experimental drugs called ALN-ANG3 and evinacumab...
Show More Location
Apogee Clinical Research, LLC
Learn More & Join Trial
Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis PHASE2 The primary objective of the study is to determine the proportion of patien...
Show More Location
Radin Cardivascular Medical Group, Inc
Learn More & Join Trial
Study to Assess the Safety and Tolerability of Single Doses of REGN1500 PHASE1 Phase 1, first-in-human, randomized, ascending single-dose, placebo-control...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers PHASE1 The primary objective of the study is to compare the safety and tolerabilit...
Show More Location
WCCT Global, Inc.
Learn More & Join Trial
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia PHASE2 The primary objective of the study is to evaluate the reduction of LDL-C by...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia PHASE3 The primary objective of the study is to demonstrate the reduction of low-d...
Show More Location
Regeneron Research Site
Learn More & Join Trial
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500 PHASE1 This is a phase 1, randomized, double-blind, placebo-controlled, multiple a...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis PHASE2 The primary objective is to determine the change in Triglyceride (TG) level...
Show More Location
Regeneron Research Facility
Learn More & Join Trial